Good stuff Joe. I know she is limited to what she can say, but...

  1. 61 Posts.
    lightbulb Created with Sketch. 22
    Good stuff Joe. I know she is limited to what she can say, but her first response about the meeting being “regarding avenues to advance in a registrational trial” makes it sound like going to phase III. But maybe it will be the required confirmatory trial for accelerated approval. Again, I think it looks good. Put together the PFS with OS and the biomarkers showing the effects and the negligible toxicity. FDA targeting drugs in high unmet needs. I guess we have to wait and see. I am concerned maybe something got leaked that they didn’t get AA and are moving forward with a standard PHIII is what is tanking our investment. Butt I wait…
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
25.0¢
Change
0.005(2.04%)
Mkt cap ! $357.7M
Open High Low Value Volume
25.0¢ 25.0¢ 25.0¢ $16.39K 65.58K

Buyers (Bids)

No. Vol. Price($)
20 498602 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 100790 10
View Market Depth
Last trade - 10.04am 17/06/2025 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.